Company / R&D Expense
UTAH MEDICAL PRODUCTS INC R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$560.0K
FY2025
5-year range
$483.0K / $560.0K
FY2021-FY2025
Trend
+13.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $447,000 in FY2019 to $560,000 in FY2025.
Based on SEC 10-K filings.
$560,000 in FY2025 with a 5-year CAGR of +4.3%.
Improved from $526,000 to $560,000 over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- +4.8%
- 5-Year CAGR
- +4.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +4.3%, indicating consistent growth.
- In FY2025, r&d expense increased 13.6% year-over-year.
- Lowest r&d expense in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 16.69 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $560.0K | +13.6% |
| FY2024 | $493.0K | -6.3% |
| FY2023 | $526.0K | +8.2% |
| FY2022 | $486.0K | +0.6% |
| FY2021 | $483.0K | +6.4% |
| FY2020 | $454.0K | +1.6% |
| FY2019 | $447.0K | -5.9% |
| FY2018 | $475.0K | -9.0% |
| FY2017 | $522.0K | +13.5% |
| FY2016 | $460.0K | -6.3% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026